CHELSEA OLIVERA—The legal and policy momentum to curb pharmaceutical pay-for-delay deals is ramping up. On September 22, 2021, Humana and Centene, two health insurance companies, individually filed lawsuits in the U.S. District Court of New Jersey against Merck, a pharmaceutical manufacturer. The health insurance companies alleged that Merck engaged in anticompetitive “pay-for-delay” practices that caused […]
NINA GRISCELLI—In October 2021, a San Francisco federal court ordered Tesla to pay $137 million in damages to Owen Diaz, a Black former worker who accused the company of turning a blind eye to discrimination and racial abuse at the company’s plant in Fremont, California. As a former contract elevator operator at one of Tesla’s […]
NICOLE PORZENHEIM—On June 25, 2021, a divided Supreme Court issued its opinion in TransUnion LLC v. Ramirez. The highly anticipated decision addressed whether the plaintiffs had Article III standing to pursue class action claims. At first glance, the Court’s answer appeared simple—no concrete harm, no standing. But, the consequences for class action litigants are far […]
OLIVIA JOHNSON—On September 20, 2021, the Miami 21 Ad Hoc Task Force adjourned for the final time with a completed Miami 21 Report ready to send to City Commissioners and the Mayor for review on October 28th. The City asked the Task Force, steeped in controversy from its inception, to review the Miami 21 Code […]
ALLY CHAMBERLIN—Earlier this month, President Joe Biden announced new Covid-19 policies regarding vaccinations. The President’s “action plan” consists of the following key components: an executive order mandating vaccinations for all federal employees; vaccine requirements for all healthcare workers employed at facilities receiving Medicare and Medicaid funding; and a requirement that all private employers with 100 […]
